{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:28:19Z","timestamp":1787506099379,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T00:00:00Z","timestamp":1553212800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1208\/s12249-019-1360-9","type":"journal-article","created":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T16:03:28Z","timestamp":1553270608000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Cocrystal of 5-Fluorouracil: Characterization and Evaluation of Biopharmaceutical Parameters"],"prefix":"10.1208","volume":"20","author":[{"given":"Manoj Kumar","family":"Gautam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mousumi","family":"Besan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renu","family":"Chadha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,22]]},"reference":[{"issue":"5","key":"1360_CR1","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc1074","volume":"3","author":"DB Longley","year":"2003","unstructured":"Longley DB, Harkin DP, Johnston PG. 5-Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3(5):330\u20138.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"1360_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s11096-006-9030-x","volume":"28","author":"S Ruth Van","year":"2006","unstructured":"Van Ruth S, Jansman FG, Sanders CJ. Total body topical 5-fluorouracil for extensive non-melanoma skin cancer. Pharm World Sci. 2006;28(3):159\u201362.","journal-title":"Pharm World Sci"},{"issue":"4","key":"1360_CR3","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3109\/10717544.2015.1124473","volume":"23","author":"A Hussain","year":"2016","unstructured":"Hussain A, Samad A, Ramzan M, Ahsan MN, Ur Rehman Z, Ahmad FJ. Elastic liposome-based gel for topical delivery of 5-fluorouracil: in vitro and in vivo investigation. Drug Deliv. 2016;23(4):1115\u201329.","journal-title":"Drug Deliv"},{"issue":"4","key":"1360_CR4","first-page":"241","volume":"53","author":"M Glavas-Dodov","year":"2003","unstructured":"Glavas-Dodov M, Fredro-Kumbaradzi E, Goracinova K, Calis S, Simonoska M, Hincal AA. 5-Fluorouracil in topical liposome gels for anticancer treatment-formulation and evaluation. Acta Pharma. 2003;53(4):241\u201350.","journal-title":"Acta Pharma"},{"issue":"1\u20132","key":"1360_CR5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ijpharm.2007.11.037","volume":"353","author":"D Paolino","year":"2008","unstructured":"Paolino D, Cosco D, Muzzalupo R, Trapasso E, Picci N, Fresta M. Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer. Int J Pharm. 2008;353(1\u20132):233\u201342.","journal-title":"Int J Pharm"},{"issue":"2","key":"1360_CR6","doi-asserted-by":"publisher","first-page":"E47","DOI":"10.1208\/pt070247","volume":"7","author":"Z Rahman","year":"2006","unstructured":"Rahman Z, Kohli K, Khar RK, Ali M, Charoo NA, Shamsher AA. Characterization of 5-fluorouracil microspheres for colonic delivery. AAPS PharmSciTech. 2006;7(2):E47\u201353.","journal-title":"AAPS PharmSciTech"},{"issue":"11","key":"1360_CR7","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.cclet.2014.06.027","volume":"25","author":"DJ Fu","year":"2014","unstructured":"Fu DJ, Jin Y, Xie MQ, Ye YJ, Qin DD, Lou KY, et al. Preparation and characterization of mPEG grafted chitosan micelles as 5-fluorouracil carriers for effective anti-tumour activity. Chin Chem Lett. 2014;25(11):1435\u201340.","journal-title":"Chin Chem Lett"},{"issue":"1","key":"1360_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1208\/s12249-015-0360-7","volume":"17","author":"H Patil","year":"2016","unstructured":"Patil H, Tiwari RV, Repka MA. Hot-melt extrusion: from theory to application in a pharmaceutical formulation. AAPS PharmSciTech. 2016;17(1):20\u201342.","journal-title":"AAPS PharmSciTech"},{"issue":"54","key":"1360_CR9","doi-asserted-by":"publisher","first-page":"8342","DOI":"10.1039\/C6CC02943D","volume":"52","author":"NA Bollag","year":"2016","unstructured":"Bollag NA. Pharmaceutical cocrystals: walking the talk. Chem Commun. 2016;52(54):8342\u201360.","journal-title":"Chem Commun"},{"issue":"8","key":"1360_CR10","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1021\/acs.cgd.5b00439","volume":"15","author":"AY Li","year":"2015","unstructured":"Li AY, Xu LL, Chen JM, Lu TB. Solubility and dissolution rate enhancement of triamterene by a cocrystallization method. Cryst Growth Des. 2015;15(8):3785\u201391.","journal-title":"Cryst Growth Des"},{"issue":"5","key":"1360_CR11","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1021\/acs.molpharmaceut.5b00020","volume":"12","author":"P Sanphui","year":"2015","unstructured":"Sanphui P, Devi VK, Clara D, Malviya N, Ganguly S, Desiraju GR. Cocrystals of hydrochlorothiazide: solubility and diffusion\/permeability enhancements through drug\u2013coformer interactions. Mol Pharm. 2015;12(5):1615\u201322.","journal-title":"Mol Pharm"},{"issue":"8","key":"1360_CR12","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1021\/acs.cgd.6b00552","volume":"16","author":"XL Dai","year":"2016","unstructured":"Dai XL, Li S, Chen JM, Lu TB. Improving the membrane permeability of 5-fluorouracil via cocrystallization. Cryst Growth Des. 2016;16(8):4430\u20138.","journal-title":"Cryst Growth Des"},{"key":"1360_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/593902","volume":"2015","author":"Y Semaming","year":"2015","unstructured":"Semaming Y, Pannengpetch P, Chattipakorn SC, Chattipakorn N. Pharmacological properties of protocatechuic acid and its potential roles as complementary medicine. Evid Based Complement Alternat Med. 2015;2015:1\u201311.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"4","key":"1360_CR14","doi-asserted-by":"publisher","first-page":"618","DOI":"10.3945\/jn.110.133843","volume":"141","author":"R Landberg","year":"2011","unstructured":"Landberg R, Sun Q, Rimm EB, Cassidy A, Scalbert A, Mantzoros CS, et al. Selected dietary flavonoids are associated with markers of inflammation and endothelial dysfunction in US women. J Nutr. 2011;141(4):618\u201325.","journal-title":"J Nutr"},{"issue":"2","key":"1360_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/1756285613512712","volume":"7","author":"HB Jensen","year":"2014","unstructured":"Jensen HB, Ravnborg M, Dalgas U, Stenager E. 4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review. Ther Adv Neurol Disord. 2014;7(2):97\u2013113.","journal-title":"Ther Adv Neurol Disord"},{"issue":"1","key":"1360_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s12247-018-9333-1","volume":"14","author":"Cecilia C. P. da Silva","year":"2018","unstructured":"Silva CCP, Cristiane CM, Souza MS, Luan FD, Renato LC, Ellena J. 5-Fluorocytosine\/5-fluorouracil drug-drug cocrystal: a new development route based on mechanochemical synthesis. J Pharm Innov. \n                    https:\/\/doi.org\/10.1007\/s12247-018-9333-1\n                    \n                  .","journal-title":"Journal of Pharmaceutical Innovation"},{"issue":"2","key":"1360_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/10837450.2018.1455210","volume":"24","author":"S Emami","year":"2019","unstructured":"Emami S, Adibkia K, Barzegar-Jalali M, Siahi-Shadbad M. Piroxicam cocrystals with phenolic coformers: preparation, characterization, and dissolution properties. Pharm Dev Technol. 2019;24(2):199\u2013210. \n                    https:\/\/doi.org\/10.1080\/10837450.2018.1455210\n                    \n                  .","journal-title":"Pharm Dev Technol"},{"issue":"8","key":"1360_CR18","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.1021\/cg3007102","volume":"12","author":"C Renu","year":"2012","unstructured":"Renu C, Anupam S, Dharamvir SJ, Venugopalan P. Preparation and solid-state characterization of three novel multicomponent solid forms of oxcarbazepine: improvement in solubility through saccharin cocrystal. Cryst Growth Des. 2012;12(8):4211\u201324.","journal-title":"Cryst Growth Des"},{"issue":"30","key":"1360_CR19","first-page":"198","volume":"154","author":"Y Caiqin","year":"2018","unstructured":"Caiqin Y, Wei G, Yulong L, Qianqian L, Jiao W, Jing W, et al. Experimental and DFT simulation study of a novel felodipine cocrystal: characterization, dissolving properties and thermal decomposition kinetics. J Pharm Biomed Anal. 2018;154(30):198\u2013206.","journal-title":"J Pharm Biomed Anal"},{"issue":"2","key":"1360_CR20","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1208\/s12249-011-9603-4","volume":"12","author":"R Ziyaur","year":"2011","unstructured":"Ziyaur R, Cyrus A, Ahmed SZ, Saeed RK, Mansoor AK. Physico-mechanical and stability evaluation of carbamazepine cocrystal with nicotinamide. AAPS PharmSciTech. 2011;12(2):693\u2013704.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"1360_CR21","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1021\/cg800685z","volume":"9","author":"N Issa","year":"2008","unstructured":"Issa N, Karamertzanis PG, Welch GW, Price SL. Can the formation of pharmaceutical cocrystals be computationally predicted? I. Comparison of lattice energies. Cryst Growth Des. 2008;9(1):442\u201353.","journal-title":"Cryst Growth Des"},{"issue":"2","key":"1360_CR22","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1107\/S0021889807067908","volume":"41","author":"CF Macrae","year":"2008","unstructured":"Macrae CF, Bruno IJ, Chisholm JA, Edgington PR, McCabe P, Pidcock E, et al. Mercury CSD 2.0\u2014new features for the visualization and investigation of crystal structures. J Appl Crystallogr. 2008;41(2):466\u201370.","journal-title":"J Appl Crystallogr"},{"issue":"1\u20132","key":"1360_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ijpharm.2005.01.004","volume":"293","author":"R Panchagnula","year":"2005","unstructured":"Panchagnula R, Bokalial R, Sharma P, Khandavilli S. Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies. Int J Pharm. 2005;293(1\u20132):213\u201323.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"1360_CR24","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ijpharm.2015.12.061","volume":"499","author":"NK Garg","year":"2016","unstructured":"Garg NK, Tyagi RK, Singh B, Sharma G, Nirbhavane P, Kushwah V, et al. Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-\u03baB and FOXO1. Int J Pharm. 2016;499(1\u20132):301\u201320.","journal-title":"Int J Pharm"},{"issue":"1","key":"1360_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/03639040701484593","volume":"34","author":"X Li","year":"2008","unstructured":"Li X, Xu Y, Chen G, Wei P, Ping Q. PLGA nanoparticles for the oral delivery of 5-fluorouracil using high-pressure homogenization-emulsification as the preparation method and in vitro\/in vivo studies. Drug Dev Ind Pharm. 2008;34(1):107\u201315.","journal-title":"Drug Dev Ind Pharm"},{"issue":"7","key":"1360_CR26","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1208\/s12249-018-1148-3","volume":"19","author":"N Pradip","year":"2018","unstructured":"Pradip N, Gajanand S, Bhupinder S, Gopal KK, Vijay GG, Patil AB, et al. Preclinical explorative assessment of celecoxib-based biocompatible lipidic nanocarriers for the management of CFA-induced rheumatoid arthritis in Wistar rats. AAPS PharmSciTech. 2018;19(7):3187\u201398. \n                    https:\/\/doi.org\/10.1208\/s12249-018-1148-3\n                    \n                  .","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"1360_CR27","doi-asserted-by":"publisher","first-page":"E39","DOI":"10.1208\/pt070488","volume":"7","author":"S\u00d6 I\u015fik","year":"2006","unstructured":"I\u015fik S\u00d6, Hatice YK, G\u00fclten K, Sumru S, Tamer G, G\u00f6khan E. Transdermal delivery of diclofenac sodium through rat skin from various formulations. AAPS PharmSciTech. 2006;7(4):E39\u201345.","journal-title":"AAPS PharmSciTech"},{"issue":"8","key":"1360_CR28","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1208\/s12249-018-1196-8","volume":"19","author":"WO David","year":"2018","unstructured":"David WO, Jasmine M. Skin penetration and permeation properties of Transcutol\u00ae\u2014neat or diluted mixtures. AAPS PharmSciTech. 2018;19(8):3512\u201333.","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"1360_CR29","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1208\/pt0804080","volume":"8","author":"S Faiyaz","year":"2007","unstructured":"Faiyaz S, Sanjula B, Alka A, Javed A, Mohammed A, Sheikh S. Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS PharmSciTech. 2007;8(4):E1\u20139.","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"1360_CR30","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1021\/cg801178m","volume":"9","author":"KB Dejan","year":"2009","unstructured":"Dejan KB, Rodger FH, Xiaochun L, Richard WD, Leonard RMG, Geoff GZZ. Cocrystals of caffeine and hydroxybenzoic acids composed of multiple supramolecular heterosynthons: screening via solution-mediated phase transformation and structural characterization. Cryst Growth Des. 2009;9(4):1932\u201343.","journal-title":"Cryst Growth Des"},{"issue":"5","key":"1360_CR31","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.bmcl.2015.01.022","volume":"25","author":"JR Wang","year":"2015","unstructured":"Wang JR, Yu X, Zhou C, Lin Y, Chen C, Pan G, et al. Improving the dissolution and bioavailability of 6-mercaptopurine via co-crystallization with isonicotinamide. Bioorg Med Chem Lett. 2015;25(5):1036\u20139.","journal-title":"Bioorg Med Chem Lett"},{"issue":"5","key":"1360_CR32","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1021\/acs.cgd.6b01769","volume":"17","author":"C Kunal","year":"2017","unstructured":"Kunal C, Maninder K, Yashika B, Renu C, Sadhika K, Sanjay M, et al. Cocrystals of hesperetin: structural, pharmacokinetic, and pharmacodynamic evaluation. Cryst Growth Des. 2017;17(5):2386\u2013405.","journal-title":"Cryst Growth Des"},{"key":"1360_CR33","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.3390\/molecules21121644","volume":"21","author":"DD Cristina","year":"2016","unstructured":"Cristina DD, Margherita L, Roberto F, Carla I, Marina I, Gaetano M, et al. Alpha and beta-cyclodextrin inclusion complexes with 5-fluorouracil: characterization and cytotoxic activity evaluation. Molecules. 2016;21:1644\u201358.","journal-title":"Molecules"},{"issue":"3","key":"1360_CR34","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jconrel.2004.06.001","volume":"98","author":"Huabing Chen","year":"2004","unstructured":"Chen H, Chang X, Weng T, Zhao X, Gao Z, Yang Y, et al. A study of microemulsion systems for transdermal delivery of triptolide. J Control Release. 2004;98(3):427\u201336.","journal-title":"Journal of Controlled Release"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-019-1360-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-019-1360-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-019-1360-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T00:05:22Z","timestamp":1584749122000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-019-1360-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,22]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["1360"],"URL":"https:\/\/doi.org\/10.1208\/s12249-019-1360-9","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,22]]},"assertion":[{"value":"18 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"149"}}